2024 Q1 Form 10-Q Financial Statement

#000149315224020681 Filed on May 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $4.082M $3.939M
YoY Change 3.64% -7.0%
Cost Of Revenue $1.277M $1.083M
YoY Change 17.83% 19.82%
Gross Profit $2.806M $2.856M
YoY Change -1.75% -14.28%
Gross Profit Margin 68.73% 72.5%
Selling, General & Admin $3.334M $3.207M
YoY Change 3.95% -37.39%
% of Gross Profit 118.81% 112.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $534.2K $541.9K
YoY Change -1.42% -10.81%
% of Gross Profit 19.04% 18.97%
Operating Expenses $9.114M $4.832M
YoY Change 88.62% -15.67%
Operating Profit -$5.032M -$893.0K
YoY Change 463.49% -62.76%
Interest Expense -$410.3K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$314.9K $3.877M
YoY Change -108.12% -66.97%
Pretax Income -$5.347M $2.984M
YoY Change -279.19% -68.05%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$5.347M -$1.789M
YoY Change 198.94% -119.15%
Net Earnings / Revenue -130.97% -45.4%
Basic Earnings Per Share -$0.81 -$1.15
Diluted Earnings Per Share -$0.81 -$1.15
COMMON SHARES
Basic Shares Outstanding 6.569M shares 1.566M shares
Diluted Shares Outstanding 6.569M shares 2.186M shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $680.1K $2.116M
YoY Change -67.86% -61.46%
Cash & Equivalents $2.113M $3.554M
Short-Term Investments
Other Short-Term Assets $1.674M $1.609M
YoY Change 3.99% 170.05%
Inventory
Prepaid Expenses
Receivables $1.027M $982.0K
Other Receivables $29.50K
Total Short-Term Assets $3.411M $4.708M
YoY Change -27.55% -35.24%
LONG-TERM ASSETS
Property, Plant & Equipment $144.7K $155.5K
YoY Change -6.94% -89.16%
Goodwill $6.693M $14.29M
YoY Change -53.15%
Intangibles $6.611M $12.89M
YoY Change -48.71%
Long-Term Investments $900.0K
YoY Change -33.33%
Other Assets $21.79K $23.29K
YoY Change -6.41% -66.63%
Total Long-Term Assets $14.12M $29.18M
YoY Change -51.59% -33.69%
TOTAL ASSETS
Total Short-Term Assets $3.411M $4.708M
Total Long-Term Assets $14.12M $29.18M
Total Assets $17.54M $33.88M
YoY Change -48.25% -33.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.180M $1.077M
YoY Change 9.63% 30.64%
Accrued Expenses $256.3K $312.6K
YoY Change -17.98% -52.14%
Deferred Revenue
YoY Change
Short-Term Debt $11.60K $38.31K
YoY Change -69.72%
Long-Term Debt Due $1.432M $1.235M
YoY Change 15.94% 34.53%
Total Short-Term Liabilities $3.531M $5.451M
YoY Change -35.22% -30.43%
LONG-TERM LIABILITIES
Long-Term Debt $10.66M $12.04M
YoY Change -11.43% 67.08%
Other Long-Term Liabilities $601.6K $958.7K
YoY Change -37.25% -96.16%
Total Long-Term Liabilities $10.66M $12.99M
YoY Change -17.96% -59.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.531M $5.451M
Total Long-Term Liabilities $10.66M $12.99M
Total Liabilities $15.57M $21.65M
YoY Change -28.06% -45.9%
SHAREHOLDERS EQUITY
Retained Earnings -$44.35M -$28.78M
YoY Change 54.09%
Common Stock $489.5K $134.7K
YoY Change 263.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.962M $12.24M
YoY Change
Total Liabilities & Shareholders Equity $17.54M $33.88M
YoY Change -48.25% -33.91%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$5.347M -$1.789M
YoY Change 198.94% -119.15%
Depreciation, Depletion And Amortization $534.2K $541.9K
YoY Change -1.42% -10.81%
Cash From Operating Activities -$204.4K -$1.065M
YoY Change -80.81% 210.21%
INVESTING ACTIVITIES
Capital Expenditures $12.31K $6.695K
YoY Change 83.9% -102.64%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$15.71K
YoY Change -100.0% -99.91%
Cash From Investing Activities -$29.44K -$96.30K
YoY Change -69.42% -99.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$392.1K $2.806M
YoY Change -113.98% -86.03%
NET CHANGE
Cash From Operating Activities -$204.4K -$1.065M
Cash From Investing Activities -$29.44K -$96.30K
Cash From Financing Activities -$392.1K $2.806M
Net Change In Cash -$625.9K $1.645M
YoY Change -138.06% 21.36%
FREE CASH FLOW
Cash From Operating Activities -$204.4K -$1.065M
Capital Expenditures $12.31K $6.695K
Free Cash Flow -$216.7K -$1.072M
YoY Change -79.78% 1091.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001812727
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
usd
CY2024Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
CY2024Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2024Q1 RELI Payments On Earnout Liabilities
PaymentsOnEarnoutLiabilities
usd
CY2024Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2024Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
CY2024Q1 RELI Warrants Exercised Or Transferred
WarrantsExercisedOrTransferred
usd
CY2024Q1 RELI Acquisitions And Settlements
AcquisitionsAndSettlements
usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
usd
CY2024Q1 RELI Earnout Liability Current
EarnoutLiabilityCurrent
usd
CY2024Q1 RELI Earnout Liability Noncurrent
EarnoutLiabilityNoncurrent
usd
CY2023Q4 RELI Earnout Liability Noncurrent
EarnoutLiabilityNoncurrent
usd
CY2024Q1 RELI Recognition And Change In Fair Value Of Warrant Liabilities
RecognitionAndChangeInFairValueOfWarrantLiabilities
usd
CY2024Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2024Q1 RELI Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
usd
CY2024Q1 RELI Changes Due To Payments
ChangesDueToPayments
usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-40020
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
RELIANCE GLOBAL GROUP, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3390293
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Blvd. of the Americas
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 105
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08701
CY2024Q1 dei City Area Code
CityAreaCode
732
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
380-4600
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8535591 shares
CY2023Q4 us-gaap Cash
Cash
1329016 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1409895 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
899 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
333756 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4379032 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
139999 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
739830 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11042757 usd
CY2023Q4 us-gaap Goodwill
Goodwill
6693099 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20292 usd
CY2023Q4 us-gaap Assets
Assets
23015009 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
835483 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
56197 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
7414 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1390766 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
285171 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
159867 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3189851 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11026971 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
484335 usd
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
173660 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
268993 usd
CY2023Q4 us-gaap Liabilities
Liabilities
15867679 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.086
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.086
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
750000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
750000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
9076 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
9076 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.086
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.086
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5692387 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5692387 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4761974 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4761974 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
409509 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45739786 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39001965 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18566 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5346663 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
7147330 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23015009 usd
CY2024Q1 RELI Commission Income
CommissionIncome
4082438 usd
CY2024Q1 us-gaap Revenues
Revenues
4082438 usd
CY2023Q1 us-gaap Revenues
Revenues
3939103 usd
CY2024Q1 RELI Commission Expense
CommissionExpense
1276542 usd
CY2023Q1 RELI Commission Expense
CommissionExpense
1083326 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
1831662 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
1755894 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1374890 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
837766 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
127042 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
136571 usd
CY2024Q1 RELI Change In Estimated Acquisition Earnout Payables
ChangeInEstimatedAcquisitionEarnoutPayables
47761 usd
CY2023Q1 RELI Change In Estimated Acquisition Earnout Payables
ChangeInEstimatedAcquisitionEarnoutPayables
476692 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
534152 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
653778 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3922110 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
9114159 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4944027 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5031721 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1004924 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3949 usd
CY2024Q1 RELI Recognition And Change In Fair Value Of Warrant Liability
RecognitionAndChangeInFairValueOfWarrantLiability
95333 usd
CY2023Q1 RELI Recognition And Change In Fair Value Of Warrant Liability
RecognitionAndChangeInFairValueOfWarrantLiability
4266231 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-314942 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3876880 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5346663 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2871956 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4660494 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5346663 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1788538 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.81
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.92
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-3.07
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.81
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.59
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-2.18
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.77
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6569019 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1553953 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6569019 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2185847 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
7147330 usd
CY2024Q1 RELI Common Shares Issued Value For Earnout Liabilities
CommonSharesIssuedValueForEarnoutLiabilities
17628 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
124649 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1961510 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8911039 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8911039 usd
CY2023Q1 RELI Common Shares Issued Value For Earnout Liabilities
CommonSharesIssuedValueForEarnoutLiabilities
982478 usd
CY2023Q1 RELI Stock Issued During Period Value Settle Loan
StockIssuedDuringPeriodValueSettleLoan
645000 usd
CY2023Q1 RELI Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
-4646 shares
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3446484 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43797 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1788538 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12235614 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12235614 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5346663 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1788538 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
534152 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
541873 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-3922110 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11721 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11721 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1110 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
5098 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18566 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
43797 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-95333 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4266231 usd
CY2024Q1 RELI Earnout Fair Value And Writeoff Adjustments
EarnoutFairValueAndWriteoffAdjustments
47761 usd
CY2023Q1 RELI Earnout Fair Value And Writeoff Adjustments
EarnoutFairValueAndWriteoffAdjustments
476692 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-277984 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23976 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-91 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-6676 usd
CY2024Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
28599 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-11464 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-92976 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-81381 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1500 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
344847 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
125229 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
16395 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-294058 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-204382 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5031116 usd
CY2023Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
3966238 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-204382 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1064878 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12312 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6695 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17132 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
73894 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-29444 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-80589 usd
CY2023Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-15708 usd
CY2024Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
858637 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29444 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96297 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
335533 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
207580 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
345000 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
44596 usd
CY2023Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
98004 usd
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
136620 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
412500 usd
CY2024Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
124649 usd
CY2023Q1 RELI Payments On Earnout Liabilities
PaymentsOnEarnoutLiabilities
250000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3446484 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-392100 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2823400 usd
CY2023Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-17700 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-392100 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2805700 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-625926 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1644525 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2738911 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1909769 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2112985 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3554294 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2113000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3411000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3531000 usd
CY2024Q1 RELI Working Capital Deficiency
WorkingCapitalDeficiency
-120000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1962000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5032000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3900000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-5347000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zAWW7dalEhZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zlUGOHCI06ke">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash
Cash
680138 usd
CY2023Q1 us-gaap Cash
Cash
2116333 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1432847 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1437961 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2112985 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3554294 usd
CY2022Q4 RELI Warrant Commitment
WarrantCommitment
6433150 usd
CY2023 RELI Warrant Commitment Unrealized Gain Loss
WarrantCommitmentUnrealizedGainLoss
5583506 usd
CY2023 RELI Warrants Exercised Or Transferred
WarrantsExercisedOrTransferred
580651 usd
CY2023Q4 RELI Warrant Commitment
WarrantCommitment
268993 usd
CY2023Q4 RELI Warrant Commitment
WarrantCommitment
268993 usd
CY2024Q1 RELI Warrant Commitment Unrealized Gain Loss
WarrantCommitmentUnrealizedGainLoss
95333 usd
CY2024Q1 RELI Warrant Commitment
WarrantCommitment
173660 usd
CY2024Q1 RELI Warrant Commitment
WarrantCommitment
173660 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
159867 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2709478 usd
CY2023 RELI Acquisitions And Settlements
AcquisitionsAndSettlements
-3260403 usd
CY2024Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
47761 usd
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
1716873 usd
CY2024Q1 RELI Earnout Payable In Common Shares
EarnoutPayableInCommonShares
-17628 usd
CY2023 RELI Earnout Payable In Common Shares
EarnoutPayableInCommonShares
-159867 usd
CY2024Q1 RELI Earnout Transferred To Loans Payable Related Parties
EarnoutTransferredToLoansPayableRelatedParties
-190000 usd
CY2023 RELI Earnout Transferred To Loans Payable Related Parties
EarnoutTransferredToLoansPayableRelatedParties
-846214 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
159867 usd
CY2023Q4 RELI Earnout Liability Current
EarnoutLiabilityCurrent
-159867 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4082438 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3939103 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Goodwill
Goodwill
14287099 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7594000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
6693099 usd
CY2024Q1 us-gaap Goodwill
Goodwill
6693099 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3922110 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14992869 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-8381654 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6611215 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19750417 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-8707660 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11042757 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1225917 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1395707 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1146882 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
807363 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
717314 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1318032 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6611215 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
12092196 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
12417737 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1431875 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1390766 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10660321 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11026971 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1055234 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1552772 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1729160 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1925603 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2106978 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
3986322 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
12356069 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
263873 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
12092196 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.000 pure
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.1275 pure
CY2024Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
12000 usd
CY2023Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
56000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.086
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5692387 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4761974 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5346663 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2983861 usd
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-5346663 usd
CY2023Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
2983861 usd
CY2023Q1 RELI Recognition And Change In Fair Value Of Warrant Liabilities
RecognitionAndChangeInFairValueOfWarrantLiabilities
-4266231 usd
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-5346663 usd
CY2023Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-1282370 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6569019 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1553953 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
631894 shares
CY2023 RELI Reclass To Loans Payable Related Parties
ReclassToLoansPayableRelatedParties
-846214 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6569019 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2185847 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.81
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.92
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.81
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.59
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
104956 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
161614 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y11M1D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0598 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
286739 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
119388 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
114572 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
118009 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
121550 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
760258 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
75946 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
684312 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
159867 usd
CY2024Q1 RELI Changes Due To Fair Value Adjustments
ChangesDueToFairValueAdjustments
47761 usd
CY2024Q1 RELI Changes Due To Amount Payable In Common Shares
ChangesDueToAmountPayableInCommonShares
-17628 usd
CY2024Q1 RELI Transfers To Loans Payable Related Parties
TransfersToLoansPayableRelatedParties
-190000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2709478 usd
CY2023 RELI Changes Due To Payments
ChangesDueToPayments
-3260403 usd
CY2023 RELI Changes Due To Fair Value Adjustments
ChangesDueToFairValueAdjustments
1716873 usd
CY2023 RELI Changes Due To Amount Payable In Common Shares
ChangesDueToAmountPayableInCommonShares
-159867 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
159867 usd

Files In Submission

Name View Source Status
0001493152-24-020681-index-headers.html Edgar Link pending
0001493152-24-020681-index.html Edgar Link pending
0001493152-24-020681.txt Edgar Link pending
0001493152-24-020681-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
reli-20240331.xsd Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
reli-20240331_cal.xml Edgar Link unprocessable
reli-20240331_def.xml Edgar Link unprocessable
reli-20240331_lab.xml Edgar Link unprocessable
reli-20240331_pre.xml Edgar Link unprocessable